- Home
- PDSB vs OPAD Comparison
PDSB vs OPAD Comparison
Compare PDSB & OPAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDSB
- OPAD
- Stock Information
- Founded
- PDSB 2005
- OPAD 2015
- Country
- PDSB United States
- OPAD United States
- Employees
- PDSB N/A
- OPAD N/A
- Industry
- PDSB Biotechnology: Pharmaceutical Preparations
- OPAD Real Estate
- Sector
- PDSB Health Care
- OPAD Finance
- Exchange
- PDSB Nasdaq
- OPAD Nasdaq
- Market Cap
- PDSB 58.7M
- OPAD N/A
- IPO Year
- PDSB N/A
- OPAD N/A
- Fundamental
- Price
- PDSB $1.16
- OPAD $1.68
- Analyst Decision
- PDSB Strong Buy
- OPAD Hold
- Analyst Count
- PDSB 3
- OPAD 5
- Target Price
- PDSB $10.00
- OPAD $3.25
- AVG Volume (30 Days)
- PDSB 794.1K
- OPAD 35.2K
- Earning Date
- PDSB 03-27-2025
- OPAD 05-05-2025
- Dividend Yield
- PDSB N/A
- OPAD N/A
- EPS Growth
- PDSB N/A
- OPAD N/A
- EPS
- PDSB N/A
- OPAD N/A
- Revenue
- PDSB N/A
- OPAD $918,819,000.00
- Revenue This Year
- PDSB $5,518.68
- OPAD $8.29
- Revenue Next Year
- PDSB N/A
- OPAD $33.17
- P/E Ratio
- PDSB N/A
- OPAD N/A
- Revenue Growth
- PDSB N/A
- OPAD N/A
- 52 Week Low
- PDSB $1.05
- OPAD $1.64
- 52 Week High
- PDSB $4.42
- OPAD $8.37
- Technical
- Relative Strength Index (RSI)
- PDSB 40.47
- OPAD 38.71
- Support Level
- PDSB $1.19
- OPAD $1.75
- Resistance Level
- PDSB $1.41
- OPAD $1.87
- Average True Range (ATR)
- PDSB 0.10
- OPAD 0.11
- MACD
- PDSB -0.01
- OPAD 0.01
- Stochastic Oscillator
- PDSB 27.63
- OPAD 6.90
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.